BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32258719)

  • 1. Studies towards the synthesis of dicarboxylic acid metabolite of mitoxantrone:
    Hrynchak I; Sousa E; de Lourdes Bastos M; Pinto M; Costa VM
    Porto Biomed J; 2017; 2(5):220-221. PubMed ID: 32258719
    [No Abstract]   [Full Text] [Related]  

  • 2. Interspecies variability in mitoxantrone metabolism using primary cultures of hepatocytes isolated from rat, rabbit and humans.
    Richard B; Fabre G; De Sousa G; Fabre I; Rahmani R; Cano JP
    Biochem Pharmacol; 1991 Jan; 41(2):255-62. PubMed ID: 1989635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and structure elucidation of urinary metabolites of mitoxantrone.
    Blanz J; Mewes K; Ehninger G; Proksch B; Greger B; Waidelich D; Zeller KP
    Cancer Res; 1991 Jul; 51(13):3427-33. PubMed ID: 2054783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aspects on the pharmacokinetics of mitoxantrone and its two major metabolites.
    Schleyer E; Kamischke A; Kaufmann CC; Unterhalt M; Hiddemann W
    Leukemia; 1994 Mar; 8(3):435-40. PubMed ID: 8127148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and metabolism of mitoxantrone in man.
    Ehninger G; Proksch B; Heinzel G; Schiller E; Weible KH; Woodward DL
    Invest New Drugs; 1985; 3(2):109-16. PubMed ID: 4019115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of mitoxantrone.
    Ehninger G; Proksch B; Heinzel G; Woodward DL
    Cancer Treat Rep; 1986 Dec; 70(12):1373-8. PubMed ID: 3791250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthracycline antibiotics derivate mitoxantrone-Destructive sorption and photocatalytic degradation.
    Štenglová-Netíková IR; Petruželka L; Šťastný M; Štengl V
    PLoS One; 2018; 13(3):e0193116. PubMed ID: 29534071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion and metabolism of mitoxantrone in rabbits.
    Richard B; Fabre G; Fabre I; Cano JP
    Cancer Res; 1989 Feb; 49(4):833-7. PubMed ID: 2912555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct determination of mitoxantrone and its mono- and dicarboxylic metabolites in plasma and urine by high-performance liquid chromatography.
    Payet B; Arnoux P; Catalin J; Cano JP
    J Chromatogr; 1988 Feb; 424(2):337-45. PubMed ID: 3372626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative metabolism of the anti-cancer agent mitoxantrone by horseradish, lacto-and lignin peroxidase.
    Brück TB; Brück DW
    Biochimie; 2011 Feb; 93(2):217-26. PubMed ID: 20887767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic studies of mitoxantrone and one of its metabolites in serum and urine in patients with advanced breast cancer.
    Rentsch KM; Schwendener RA; Pestalozzi BC; Sauter C; Wunderli-Allenspach H; Hänseler E
    Eur J Clin Pharmacol; 1998 Mar; 54(1):83-9. PubMed ID: 9591936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of mitoxantrone in man and laboratory animals.
    Batra VK; Morrison JA; Woodward DL; Siverd NS; Yacobi A
    Drug Metab Rev; 1986; 17(3-4):311-29. PubMed ID: 3552542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and separation of mitoxantrone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Ehninger G; Proksch B; Schiller E
    J Chromatogr; 1985 Jul; 342(1):119-27. PubMed ID: 4044741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic oxidative activation and transformation of the antitumor agent mitoxantrone.
    Kolodziejczyk P; Reszka K; Lown JW
    Free Radic Biol Med; 1988; 5(1):13-25. PubMed ID: 3254299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the peroxidase-derived metabolite of mitoxantrone with nucleic acids. Evidence for covalent binding of 14C-labeled drug.
    Reszka K; Hartley JA; Kolodziejczyk P; Lown JW
    Biochem Pharmacol; 1989 Dec; 38(23):4253-60. PubMed ID: 2597197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and metabolism of mitoxantrone. A review.
    Ehninger G; Schuler U; Proksch B; Zeller KP; Blanz J
    Clin Pharmacokinet; 1990 May; 18(5):365-80. PubMed ID: 2185907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for oxidative activation of mitoxantrone in human, pig, and rat.
    Blanz J; Mewes K; Ehninger G; Proksch B; Waidelich D; Greger B; Zeller KP
    Drug Metab Dispos; 1991; 19(5):871-80. PubMed ID: 1686230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Horseradish peroxidase-catalyzed oxidation of mitoxantrone: spectrophotometric and electron paramagnetic resonance studies.
    Reszka K; Kolodziejczyk P; Lown JW
    J Free Radic Biol Med; 1986; 2(1):25-32. PubMed ID: 3021839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freshly isolated or cryopreserved human hepatocytes in primary culture: Influence of drug metabolism on hepatotoxicity.
    de Sousa G; Dou M; Barbe D; Lacarelle B; Placidi M; Rahmani R
    Toxicol In Vitro; 1991; 5(5-6):483-6. PubMed ID: 20732061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity.
    Rossato LG; Costa VM; de Pinho PG; Arbo MD; de Freitas V; Vilain L; de Lourdes Bastos M; Palmeira C; Remião F
    Arch Toxicol; 2013 Oct; 87(10):1809-20. PubMed ID: 23545721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.